Skip to main content
Caplight Logo









Immobazyme

Immobazyme

Private
Cape TownHealthcare & Life Scienceshttps://www.immobazyme.com/

Last Round

VC Round

Dec 1, 2025

Company Overview

Immobazyme is a biotechnology company that develops and manufactures high-value biological products, including recombinant growth factors, enzymes, and peptides, using a proprietary precision fermentation and enzyme immobilization platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing, Sustainable Materials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

precision fermentationrecombinant proteinsenzyme immobilizationcellular agriculturebiomanufacturinggrowth factorsanimal-free ingredientscultivated meatlab-grown meatindustrial enzymescontract researchbioprocessingserum replacementbiotechalternative protein

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Immobazyme Comparables

Compare Immobazyme with similar companies based on industry and business-model similarity.

Immobazyme comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sticta Biologicals
85%
Cascade Bio
74%
EnginZyme
71%

Immobazyme Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 1, 2025
VC RoundJun 18, 2024

Key People

Founding team and executive leadership

Ethan Hunter

Co-Founder & COO

Founding Team

Dominic Nicholas

Chief Executive Officer

Executive Team

Immobazyme Investors

Notable investors and investment history

Immobazyme investors
InvestorRounds
Fireball CapitalVC Round
InnovusVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 23, 2026

    Grew 31% QoQ, from 13 to 17 employees.

  • Jan 22, 2026

    Monthly visitors increased 835% MoM to 2.1K.

Immobazyme Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Immobazyme Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Immobazyme's valuation, stock price, and market status.

Firmographic Details

HeadquartersCape Town
Employee Range18
Year Founded2019
Last FundingDec 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?